Author

Maria Esther Gonzalez Garcia

OpenAlex ID: A5101248109

Efficacy and Safety of Anselamimab in Immunoglobulin Light Chain Amyloidosis: Results From the Randomized CARES Trials

2026 · Ashutosh D. Wechalekar, Angela Dispenzieri, et al. · Journal of Clinical Oncology · 2

P-325 Standard of care (SOC) outcomes in the last 3 years in patients with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM): the first pooled analysis of LocoMMotion and MoMMent trials

2023 · Katja Weisel, Maria-Victoria Mateos, et al. · Clinical Lymphoma Myeloma & Leukemia · 2

OA-64 Belantamab Mafodotin in Combination with VRd for the Treatment of Newly Diagnosed Transplant Eligible Multiple Myeloma Patients: Results from the Phase II, Open Label, Multicenter, GEM-BELAVRd Trial

2024 · Verónica González-Calle, Beatriz Rey-Bua, et al. · Clinical Lymphoma Myeloma & Leukemia

Works count: 3

Citation count: 4

H-index: 2

I10-index: